TWIST1 associates with NF-κB subunit RELA via carboxyl-terminal WR domain to promote cell autonomous invasion through IL8 production

BMC Biology

Volumn 10, Issue , 2012, Pages

  Li, Shan ^a   Kendall, Stephen E ^a,c   Raices, Raquel ^a,g   Finlay, James ^a   Covarrubias, Maricela ^a,d   Liu, Zheng ^a   Lowe, Gina ^a   Lin, Yu Huey ^a,b   Teh, Yuan H ^a,b   Leigh, Victoria ^a,e   Dhillon, Simi ^a,f   Flanagan, Steven ^a   Aboody, Karen S ^a   Glackin, Carlotta A ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

^c GeneTex   (United States)

^d Thermo Fisher Scientific   (United States)

^e WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g StemCell Technologies Inc   (Canada)

Author keywords

IL8; NF B; RELA; TWIST1; WR domain

Indexed keywords

IL8 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; NUCLEAR PROTEIN; RELA PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN;

ARTICLE; BREAST TUMOR; CANCER INVASION; CHEMISTRY; FEMALE; GENETICS; HUMAN; METABOLISM; PROMOTER REGION; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; INTERLEUKIN-8; NEOPLASM INVASIVENESS; NF-KAPPA B; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTOR RELA; TWIST TRANSCRIPTION FACTOR;

EID: 84864942150     PISSN: None     EISSN: 17417007     Source Type: Journal    
DOI: 10.1186/1741-7007-10-73     Document Type: Article

References (62)

1. Sporn MB. The war on cancer. The Lancet 1996, 347:1377-1381.
2. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939. 10.1016/j.cell.2004.06.006, 15210113.
3. Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C, Zhang X, Chua CW, Chan KW, Chan FL, Glackin C, Wong YC, Wang X. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 2005, 65:5153-5162. 10.1158/0008-5472.CAN-04-3785, 15958559.
4. Kajiyama H, Hosono S, Terauchi M, Shibata K, Ino K, Yamamoto E, Nomura S, Nawa A, Kikkawa F. Twist expression predicts poor clinical outcome of patients with clear cell carcinoma of the ovary. Oncology 2006, 71:394-401. 10.1159/000107108, 17690559.
5. Ou DL, Chien HF, Chen CL, Lin TC, Lin LI. Role of Twist in head and neck carcinoma with lymph node metastasis. Anticancer Res 2008, 28:1355-1359.
6. Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Tanaka S, Nishina S, Nakanishi Y, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yagi T, Yamamoto K. Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 2009, 9:240. 10.1186/1471-2407-9-240, 2720986, 19615090.
7. Ru GQ, Wang HJ, Xu WJ, Zhao ZS. Upregulation of Twist in Gastric Carcinoma Associated with Tumor Invasion and Poor Prognosis. Pathology Oncology Research 2010, 1-7.
8. Chen ZF, Behringer RR. twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 1995, 9:686-699. 10.1101/gad.9.6.686, 7729687.
9. Gitelman I. Twist protein in mouse embryogenesis. Dev Biol 1997, 189:205-214. 10.1006/dbio.1997.8614, 9299114.
10. Vesuna F, van Diest P, Chen JH, Raman V. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochemical and Biophysical Research Communications 2008, 367:235-241. 10.1016/j.bbrc.2007.11.151, 2696127, 18062917.
11. Casas E, Kim J, Bendesky A, Ohno-Machado L, Wolfe CJ, Yang J. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res 2011, 71:245-254. 10.1158/0008-5472.CAN-10-2330, 3025803, 21199805.
12. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009, 119:1417-1419. 10.1172/JCI39675, 2689122, 19487817.
13. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564. 10.1126/science.1203543, 21436443.
14. Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang L-H. Twist Transcriptionally Up-regulates AKT2 in Breast Cancer Cells Leading to Increased Migration, Invasion, and Resistance to Paclitaxel. Cancer research 2007, 67:1979-1987. 10.1158/0008-5472.CAN-06-1479, 17332325.
15. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688. 10.1038/nature06174, 17898713.
16. Eckert Mark A, Lwin Thinzar M, Chang Andrew T, Kim J, Danis E, Ohno-Machado L, Yang J. Twist1-Induced Invadopodia Formation Promotes Tumor Metastasis. Cancer Cell 2011, 19:372-386. 10.1016/j.ccr.2011.01.036, 3072410, 21397860.
17. Castanon I, Baylies MK. A Twist in fate: evolutionary comparison of Twist structure and function. Gene 2002, 287:11-22. 10.1016/S0378-1119(01)00893-9, 11992718.
18. El Ghouzzi V, Legeai-Mallet L, Benoist-Lasselin C, Lajeunie E, Renier D, Munnich A, Bonaventure J. Mutations in the basic domain and the loop-helix II junction of TWIST abolish DNA binding in Saethre-Chotzen syndrome. FEBS Lett 2001, 492:112-118. 10.1016/S0014-5793(01)02238-4, 11248247.
19. Gripp KW, Zackai EH, Stolle CA. Mutations in the human TWIST gene. Human Mutation 2000, 15:150-155. 10.1002/(SICI)1098-1004(200002)15:2<150::AID-HUMU3>3.0.CO;2-D, 10649491.
20. Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz de Luna RI, Garcia Delgado C, Gonzalez-Ramos M, Kline AD, Jabs EW. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 1997, 15:36-41. 10.1038/ng0197-36, 8988166.
21. Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N, Wu H, Yu K, Ornitz DM, Olson EN, Justice MJ, Karsenty G. A Twist Code Determines the Onset of Osteoblast Differentiation. Developmental Cell 2004, 6:423-435. 10.1016/S1534-5807(04)00058-9, 15030764.
22. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
23. Liu M, Ju X, Willmarth NE, Casimiro MC, Ojeifo J, Sakamaki T, Katiyar S, Jiao X, Popov VM, Yu Z, Wu K, Joyce D, Wang C, Pestell RG. Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. Am J Pathol 2009, 174:1910-1920. 10.2353/ajpath.2009.080706, 2671278, 19349372.
24. Mukaida N, Mahe Y, Matsushima K. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 1990, 265:21128-21133.
25. Stein B, Baldwin AS. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol Cell Biol 1993, 13:7191-7198. 364780, 8413306.
26. Sosic D, Richardson JA, Yu K, Ornitz DM, Olson EN. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 2003, 112:169-180. 10.1016/S0092-8674(03)00002-3, 12553906.
27. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 1995, 14:2876-2883. 398406, 7796813.
28. Shirokawa JM, Courey AJ. A direct contact between the dorsal rel homology domain and Twist may mediate transcriptional synergy. Mol Cell Biol 1997, 17:3345-3355. 232187, 9154833.
29. Chakrabarti S, Patel KD. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J Leukoc Biol 2005, 78:279-288. 10.1189/jlb.1004612, 15831558.
30. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003, 170:3369-3376.
31. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, Sarau HM. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 1998, 273:10095-10098. 10.1074/jbc.273.17.10095, 9553055.
32. Casilli F, Bianchini A, Gloaguen I, Biordi L, Alesse E, Festuccia C, Cavalieri B, Strippoli R, Cervellera MN, Di Bitondo R, Ferretti E, Mainiero F, Bizzarri C, Colotta F, Bertini R. Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2. Biochem Pharmacol 2005, 69:385-394. 10.1016/j.bcp.2004.10.007, 15652230.
33. Calza S, Hall P, Auer G, Bjohle J, Klaar S, Kronenwett U, Liu ET, Miller L, Ploner A, Smeds J, Bergh J, Pawitan Y. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res 2006, 8:R34. 10.1186/bcr1517, 1779468, 16846532.
34. Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY, Nakatani Y, Kedes L. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 1999, 96:405-413. 10.1016/S0092-8674(00)80553-X, 10025406.
35. Hamamori Y, Wu HY, Sartorelli V, Kedes L. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist. Mol Cell Biol 1997, 17:6563-6573. 232510, 9343420.
36. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260. 10.1146/annurev.immunol.16.1.225, 9597130.
37. Baker RG, Hayden MS, Ghosh S. NF-[kappa]B, Inflammation, and Metabolic Disease. Cell Metabolism 2011, 13:11-22. 10.1016/j.cmet.2010.12.008, 3040418, 21195345.
38. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-[kappa]B as the matchmaker. Nat Immunol 2011, 12:715-723.
39. Bollrath J, Greten FR. IKK/NF-[kappa]B and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 2009, 10:1314-1319. 10.1038/embor.2009.243, 2799209, 19893576.
40. Jiang J, Kosman D, Ip YT, Levine M. The dorsal morphogen gradient regulates the mesoderm determinant twist in early Drosophila embryos. Genes & Development 1991, 5:1881-1891. 10.1101/gad.5.10.1881, 22888464.
41. Ip YT, Park RE, Kosman D, Yazdanbakhsh K, Levine M. dorsal-twist interactions establish snail expression in the presumptive mesoderm of the Drosophila embryo. Genes Dev 1992, 6:1518-1530. 10.1101/gad.6.8.1518, 1644293.
42. Szymanski P, Levine M. Multiple modes of dorsal-bHLH transcriptional synergy in the Drosophila embryo. EMBO J 1995, 14:2229-2238. 398329, 7774581.
43. Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, Kuntzen C, Franzoso G. Upregulation of Twist-1 by NF-κB Blocks Cytotoxicity Induced by Chemotherapeutic Drugs. Molecular and Cellular Biology 2007, 27:3920-3935. 10.1128/MCB.01219-06, 1900008, 17403902.
44. Derin D, Soydinc HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E. Serum IL-8 and IL-12 levels in breast cancer. Med Oncol 2007, 24:163-168. 10.1007/BF02698035, 17848739.
45. De Larco JE, Wuertz BR, Rosner KA, Erickson SA, Gamache DE, Manivel JC, Furcht LT. A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol 2001, 158:639-646. 10.1016/S0002-9440(10)64005-9, 1850317, 11159200.
46. Green AR, Green VL, White MC, Speirs V. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int J Cancer 1997, 72:937-941. 10.1002/(SICI)1097-0215(19970917)72:6<937::AID-IJC3>3.0.CO;2-Q, 9378554.
47. Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpé S, Vermeulen PB, Dirix LY. Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival. Clinical Cancer Research 2004, 10:7157-7162. 10.1158/1078-0432.CCR-04-0812, 15534087.
48. Orditura M, De Vita F, Catalano G, Infusino S, Lieto E, Martinelli E, Morgillo F, Castellano P, Pignatelli C, Galizia G. Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis. J Interferon Cytokine Res 2002, 22:1129-1135. 10.1089/10799900260442557, 12513912.
49. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008, 14:6735-6741. 10.1158/1078-0432.CCR-07-4843, 18980965.
50. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989, 84:1045-1049. 10.1172/JCI114265, 329758, 2677047.
51. Hunninghake GW, Gadek JE, Lawley TJ, Crystal RG. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1981, 68:259-269. 10.1172/JCI110242, 370793, 7251862.
52. Idell S, Kucich U, Fein A, Kueppers F, James HL, Walsh PN, Weinbaum G, Colman RW, Cohen AB. Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985, 132:1098-1105.
53. Rola-Pleszczynski M, Gouin S, Begin R. Asbestos-induced lung inflammation. Role of local macrophage-derived chemotactic factors in accumulation of neutrophils in the lungs. Inflammation 1984, 8:53-62. 10.1007/BF00918353, 6715031.
54. Schmidt KG, Rasmussen JW, Wedebye IM, Frederiksen PB, Pedersen NT. Accumulation of Indium-111-Labeled Granulocytes in Malignant Tumors. Journal of Nuclear Medicine 1988, 29:479-484.
55. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009, 16:183-194. 10.1016/j.ccr.2009.06.017, 2754404, 19732719.
56. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801. 10.1126/science.1281554, 1281554.
57. Mironchik Y, Winnard PT, Vesuna F, Kato Y, Wildes F, Pathak AP, Kominsky S, Artemov D, Bhujwalla Z, Van Diest P, Burger H, Glackin C, Raman V. Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer. Cancer research 2005, 65:10801-10809. 10.1158/0008-5472.CAN-05-0712, 16322226.
58. Vesuna F, Lisok A, Kimble B, Raman V. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 2009, 11:1318-1328. 2794513, 20019840.
59. Lee MS, Lowe GN, Strong DD, Wergedal JE, Glackin CA. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 1999, 75:566-577. 10.1002/(SICI)1097-4644(19991215)75:4<566::AID-JCB3>3.0.CO;2-0, 10572240.
60. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30:256-268. 10.1016/S1046-2023(03)00032-X, 12798140.
61. Merritt WM, Lin YG, Spannuth WA, Fletcher MS, Kamat AA, Han LY, Landen CN, Jennings N, De Geest K, Langley RR, Villares G, Sanguino A, Lutgendorf SK, Lopez-Berestein G, Bar-Eli MM, Sood AK. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J Natl Cancer Inst 2008, 100:359-372. 10.1093/jnci/djn024, 2770251, 18314475.
62. Nelson JD, Denisenko O, Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc 2006, 1:179-185. 10.1038/nprot.2006.27, 17406230.